Recombinant human granulocyte-macrophage colony stimulating factor (rhGM-CSF) administration after autologous bone marrow transplantation for acute myeloblastic leukemia enhances activated killer cell function and may diminish leukemic relapse. [electronic resource]
Producer: 19951019Description: 721-6 p. digitalISSN:- 0268-3369
- Adolescent
- Adult
- Bone Marrow Transplantation -- immunology
- Child
- Child, Preschool
- Female
- Granulocyte-Macrophage Colony-Stimulating Factor -- administration & dosage
- Humans
- Killer Cells, Natural -- immunology
- Leukemia, Myeloid, Acute -- immunology
- Lymphocyte Activation
- Male
- Middle Aged
- Recombinant Proteins -- administration & dosage
- Recurrence
- Transplantation, Autologous
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.